Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Current Opinion in Hematology|November 19, 2004
Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphomaArjan A van de Loosdrecht, Peter C Huijgens, Gert J Ossenkoppele
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Current Oncology Reports|June 2, 2022
Older Patients with Acute Myeloid Leukemia Deserve Individualized TreatmentDavid C de Leeuw, Gert J Ossenkoppele, Jeroen J W M Janssen
Cytometry. Part B, Clinical Cytometry|December 7, 2007
Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplantsNicole Feller, Angèle Kelder, Guus Westra, et al.
Immunobiology|August 22, 2006
Feasibility of clinical dendritic cell vaccination in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|September 17, 2005
Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunizationIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Haematologica|March 15, 2006
Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|August 22, 2006
Principles of dendritic cell-based immunotherapy in myeloid leukemiaTheresia M Westers, Ilse Houtenbos, Arjan A van de Loosdrecht, et al.
Haematologica|January 2, 2016
Risk factors for relapse after allogeneic transplantation in acute myeloid leukemiaGert J Ossenkoppele, Jeroen J W M Janssen, Arjan A van de Loosdrecht
Cancers|July 1, 2017
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?Tania Martiáñez Canales, David C de Leeuw, Eline Vermue, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Current Opinion in Hematology|November 19, 2004
Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphomaArjan A van de Loosdrecht, Peter C Huijgens, Gert J Ossenkoppele
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Current Oncology Reports|June 2, 2022
Older Patients with Acute Myeloid Leukemia Deserve Individualized TreatmentDavid C de Leeuw, Gert J Ossenkoppele, Jeroen J W M Janssen
Cytometry. Part B, Clinical Cytometry|December 7, 2007
Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplantsNicole Feller, Angèle Kelder, Guus Westra, et al.
Immunobiology|August 22, 2006
Feasibility of clinical dendritic cell vaccination in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|September 17, 2005
Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunizationIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Haematologica|March 15, 2006
Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemiaIlse Houtenbos, Theresia M Westers, Gert J Ossenkoppele, et al.
Immunobiology|August 22, 2006
Principles of dendritic cell-based immunotherapy in myeloid leukemiaTheresia M Westers, Ilse Houtenbos, Arjan A van de Loosdrecht, et al.
Haematologica|January 2, 2016
Risk factors for relapse after allogeneic transplantation in acute myeloid leukemiaGert J Ossenkoppele, Jeroen J W M Janssen, Arjan A van de Loosdrecht
Cancers|July 1, 2017
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?Tania Martiáñez Canales, David C de Leeuw, Eline Vermue, et al.
Pageof 20